Latest News, Press Releases & Events

Spyryx Biosciences Appoints Alistair Wheeler, MD MFPM as Chief Medical Officer, SPX-101 Advancing in Phase 1 as Novel Therapy for Cystic Fibrosis

Spyryx Biosciences Expands Executive Team, Appoints Pulmonary Industry Leader, Alistair Wheeler, MD, MFPM as Chief Medical Officer Recognized Expert in Respiratory Product Development SPX-101 Advancing in Phase 1 as Novel Therapy for Cystic Fibrosis Durham, NC; August 18, 2016 – Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for respiratory diseases, including cystic […]

Continue Reading